Sof Andrikopoulos

What Gets Measured Gets Improved-Setting Standards and Accreditation for Quality Improvement for Diabetes Services in Australia.

Sofianos Andrikopoulos, Steven James, Natalie Wischer

Journal article  |  2021  |  J Diabetes Sci Technol

The purpose of this article is to illustrate that setting standards of care is the cornerstone for excellence in diabetes manageme..

Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group

Anthony J Pease, Sofianos Andrikopoulos, Mary B Abraham, Maria E Craig, Brett Fenton, Jane Overland, Sarah Price, David Simmons, Glynis P Ross

Journal article  |  2021  |  MEDICAL JOURNAL OF AUSTRALIA

INTRODUCTION: Type 1 diabetes presents significant challenges for optimal management. Despite intensive glycaemic control being th..

Glycaemia and utilisation of technology across the lifespan of adults with type 1 diabetes: Results of the Australian National Diabetes Audit (ANDA)

Anthony Pease, Naomi Szwarcbard, Arul Earnest, Sofianos Andrikopoulos, Natalie Wischer, Sophia Zoungas

Journal article  |  2021  |  DIABETES RESEARCH AND CLINICAL PRACTICE

AIMS: To evaluate the utilisation of technologies and associated glycaemia among adults with type 1 diabetes. METHODS: De-identifi..

The association of smoking status with glycemic control, metabolic profile and diabetic complications- Results of the Australian National Diabetes Audit (ANDA)

N Szwarcbard, M Villani, A Earnest, J Flack, S Andrikopoulos, N Wischer, G Soldatos, D Gasevic, S Zoungas

Journal article  |  2020  |  JOURNAL OF DIABETES AND ITS COMPLICATIONS

BACKGROUND: Tobacco smoking and diabetes mellitus contribute significantly to the overall health burden and mortality of Australia..

Restriction of essential amino acids dictates the systemic metabolic response to dietary protein dilution

Yann W Yap, Patricia M Rusu, Andrea Y Chan, Barbara C Fam, Andreas Jungmann, Samantha M Solon-Biet, Christopher K Barlow, Darren J Creek, Cheng Huang, Ralf B Schittenhelm, Bruce Morgan, Dieter Schmoll, Bente Kiens, Matthew DW Piper, Mathias Heikenwaelder, Stephen J Simpson, Stefan Broer, Sofianos Andrikopoulos, Oliver J Mueller, Adam J Rose

Journal article  |  2020  |  NATURE COMMUNICATIONS

Dietary protein dilution (DPD) promotes metabolic-remodelling and -health but the precise nutritional components driving this resp..

Impaired exercise performance is independent of inflammation and cellular stress following genetic reduction or deletion of selenoprotein S

Alex Bernard Addinsall, Craig Robert Wright, Taryan L Kotsiakos, Zoe M Smith, Taylah R Cook, Sofianos Andrikopoulos, Chris van der Poel, Nicole Stupka

Journal article  |  2020  |  AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Selenoprotein S (Seps1) can be protective against oxidative, endoplasmic reticulum (ER), and inflammatory stress. Seps1 global kno..

E2f8 and Dlg2 genes have independent effects on impaired insulin secretion associated with hyperglycaemia

Chieh-Hsin Yang, Salvatore P Mangiafico, Michaela Waibel, Thomas Loudovaris, Kim Loh, Helen E Thomas, Grant Morahan, Sofianos Andrikopoulos

Journal article  |  2020  |  DIABETOLOGIA

AIMS/HYPOTHESIS: Reduced insulin secretion results in hyperglycaemia and diabetes involving a complex aetiology that is yet to be ..

Breathing life into Australian diabetes clinical guidelines

Heath White, Britta Tendal, Julian Elliott, Tari Turner, Sofianos Andrikopoulos, Sophia Zoungas

Journal article  |  2020  |  MEDICAL JOURNAL OF AUSTRALIA

Continuing the success of Journal of Endocrinology and Journal of Molecular Endocrinology.

S Andrikopoulos, C Farquharson, M Haluzik

Journal article  |  2020  |  J Endocrinol

Metformin: time to review its role and safety in chronic kidney disease

Cara Tanner, Gayathiri Wang, Nancy Liu, Sofianos Andrikopoulos, Jeffrey D Zajac, Elif I Ekinci

Journal article  |  2019  |  MEDICAL JOURNAL OF AUSTRALIA

■Metformin is recommended as first-line therapy for type 2 diabetes because of its safety, low cost and potential cardiovascular b..